179 related articles for article (PubMed ID: 29641598)
1. Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway.
Li JR; Zhao YS; Chang Y; Yang SC; Guo YJ; Ji ES
PLoS One; 2018; 13(4):e0195604. PubMed ID: 29641598
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Rho-kinase Attenuates Left Ventricular Remodeling Caused by Chronic Intermittent Hypoxia in Rats via Suppressing Myocardial Inflammation and Apoptosis.
Wang ZH; Zhu D; Xie S; Deng Y; Pan Y; Ren J; Liu HG
J Cardiovasc Pharmacol; 2017 Aug; 70(2):102-109. PubMed ID: 28437280
[TBL] [Abstract][Full Text] [Related]
3. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
4. The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia.
Lu W; Kang J; Hu K; Tang S; Zhou X; Xu L; Li Y; Yu S
Sleep Breath; 2017 Sep; 21(3):667-677. PubMed ID: 28078487
[TBL] [Abstract][Full Text] [Related]
5. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
Eisa-Beygi S; Wen XY
Antiviral Res; 2015 Feb; 114():53-6. PubMed ID: 25512227
[TBL] [Abstract][Full Text] [Related]
6. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate potentiates endothelial dysfunction via reciprocal role for reactive oxygen species and RhoA/ROCK signaling in 5/6 nephrectomized rats.
Chu S; Mao X; Guo H; Wang L; Li Z; Zhang Y; Wang Y; Wang H; Zhang X; Peng W
Free Radic Res; 2017 Mar; 51(3):237-252. PubMed ID: 28277985
[TBL] [Abstract][Full Text] [Related]
8. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats.
Tsounapi P; Saito M; Kitatani K; Dimitriadis F; Ohmasa F; Shimizu S; Kinoshita Y; Takenaka A; Satoh K
Eur J Pharmacol; 2012 Sep; 691(1-3):182-9. PubMed ID: 22819709
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
Sezen SF; Lagoda G; Musicki B; Burnett AL
J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
[TBL] [Abstract][Full Text] [Related]
10. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
Zhuang R; Wu J; Lin F; Han L; Liang X; Meng Q; Jiang Y; Wang Z; Yue A; Gu Y; Fan H; Zhou X; Liu Z
Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
[TBL] [Abstract][Full Text] [Related]
11. NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.
de Frutos S; Caldwell E; Nitta CH; Kanagy NL; Wang J; Wang W; Walker MK; Gonzalez Bosc LV
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H356-63. PubMed ID: 20495147
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 and ET receptors impair left ventricular function by mediated coronary arteries dysfunction in chronic intermittent hypoxia rats.
Wang JW; Li AY; Guo QH; Guo YJ; Weiss JW; Ji ES
Physiol Rep; 2017 Jan; 5(1):. PubMed ID: 28057852
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia.
Guo QH; Tian YL; Wang Z; Li AY; Ma ZH; Guo YJ; Weiss JW; Ji ES; Chu L
Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):449-57. PubMed ID: 23662699
[TBL] [Abstract][Full Text] [Related]
14. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
[TBL] [Abstract][Full Text] [Related]
15. RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism.
Na W; Peng G; Jianping Z; Yanzhong C; Shengjiang G; Li C
Toxicol Ind Health; 2012 Oct; 28(9):831-9. PubMed ID: 22072613
[TBL] [Abstract][Full Text] [Related]
16. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
Li WJ; Park K; Paick JS; Kim SW
J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
[TBL] [Abstract][Full Text] [Related]
18. Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
Lopez NC; Ebensperger G; Herrera EA; Reyes RV; Calaf G; Cabello G; Moraga FA; Beñaldo FA; Diaz M; Parer JT; Llanos AJ
Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1053-63. PubMed ID: 26911462
[TBL] [Abstract][Full Text] [Related]
19. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK
Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
